Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Rabbit Anti-Human OCT4 monoclonal antibody, clone U.742.0


View Antibody details

Rabbit Anti-Human OLIG1 Monoclonal Antibody, Clone S18-2I6


View Antibody details

Rabbit Anti-Human OPN-R monoclonal antibody, clone 35I6M4


View Antibody details

Rabbit Anti-Human OTX2 monoclonal antibody, clone 25I25M6


View Antibody details

Rabbit Anti-Human P-Selectin monoclonal antibody, clone 4I30M20


View Antibody details

Rabbit Anti-Human p21 monoclonal antibody, clone S.330.7


View Antibody details

Rabbit Anti-Human P2Y12 monoclonal antibody, clone 5I6M20


View Antibody details

Rabbit Anti-Human p35 monoclonal antibody, clone C.44.4


View Antibody details

Rabbit Anti-Human p38 MAPK alpha (phospho Thr180, Tyr182) monoclonal antibody, clone T.528.2


View Antibody details

Rabbit Anti-Human p53 (Acetyl-Lys382) monoclonal antibody, clone 20 I24M25


View Antibody details